Secure Transfusion Solutions

Secure Transfusion Solutions, formerly known as Secure Transfusion Services, was a private U.S. life sciences and healthcare services company focused on improving the quality, safety, and availability of transfusable blood components, especially apheresis platelets. The company operated donor-facing blood collection centers under the Trusting Heart Blood Center brand and positioned its model as a modernized, compensated-donor approach to help address chronic platelet shortages. It also reported receiving FDA approval of its first Biologics License Application in January 2023, enabling licensed blood component operations. Although the business had previously raised venture financing and generated revenue, multiple recent business-data sources describe the company as out of business. The company should be understood primarily as a blood collection and transfusion-services operator rather than a traditional therapeutic drug developer.